» Articles » PMID: 21385378

Endotoxin-activated Microglia Injure Brain Derived Endothelial Cells Via NF-κB, JAK-STAT and JNK Stress Kinase Pathways

Overview
Publisher Biomed Central
Date 2011 Mar 10
PMID 21385378
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We previously showed that microglia damage blood brain barrier (BBB) components following ischemic brain insults, but the underlying mechanism(s) is/are not well known. Recent work has established the contribution of toll-like receptor 4 (TLR4) activation to several brain pathologies including ischemia, neurodegeneration and sepsis. The present study established the requirement of microglia for lipopolysaccharide (LPS) mediated endothelial cell death, and explored pathways involved in this toxicity. LPS is a classic TLR4 agonist, and is used here to model aspects of brain conditions where TLR4 stimulation occurs.

Methods/results: In monocultures, LPS induced death in microglia, but not brain derived endothelial cells (EC). However, LPS increased EC death when cocultured with microglia. LPS led to nitric oxide (NO) and inducible NO synthase (iNOS) induction in microglia, but not in EC. Inhibiting microglial activation by blocking iNOS and other generators of NO or blocking reactive oxygen species (ROS) also prevented injury in these cocultures. To assess the signaling pathway(s) involved, inhibitors of several downstream TLR-4 activated pathways were studied. Inhibitors of NF-κB, JAK-STAT and JNK/SAPK decreased microglial activation and prevented cell death, although the effect of blocking JNK/SAPK was rather modest. Inhibitors of PI3K, ERK, and p38 MAPK had no effect.

Conclusions: We show that LPS-activated microglia promote BBB disruption through injury to endothelial cells, and the specific blockade of JAK-STAT, NF-κB may prove to be especially useful anti-inflammatory strategies to confer cerebrovascular protection.

Citing Articles

Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus.

Choe K, Park J, Park H, Tahir M, Park T, Kim M Front Nutr. 2024; 11:1414696.

PMID: 39050141 PMC: 11266137. DOI: 10.3389/fnut.2024.1414696.


Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood-Brain Barrier.

Seoane N, Picos A, Morana-Fernandez S, Schmidt M, Dolga A, Campos-Toimil M Cells. 2024; 13(10.

PMID: 38786065 PMC: 11119468. DOI: 10.3390/cells13100843.


Microglia at the blood brain barrier in health and disease.

Mayer M, Fischer T Front Cell Neurosci. 2024; 18():1360195.

PMID: 38550920 PMC: 10976855. DOI: 10.3389/fncel.2024.1360195.


Recent Developments and Application of Mass Spectrometry Imaging in N-Glycosylation Studies: An Overview.

Kumar B Mass Spectrom (Tokyo). 2024; 13(1):A0142.

PMID: 38435075 PMC: 10904931. DOI: 10.5702/massspectrometry.A0142.


Single-Cell Transcriptomic Sequencing Reveals Tissue Architecture and Deciphers Pathological Reprogramming During Retinal Ischemia in Macaca fascicularis.

Li L, Zuo S, Liu Y, Yang L, Ge S, Ye F Invest Ophthalmol Vis Sci. 2024; 65(1):27.

PMID: 38214685 PMC: 10790672. DOI: 10.1167/iovs.65.1.27.


References
1.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

2.
Caso J, Pradillo J, Hurtado O, Leza J, Moro M, Lizasoain I . Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008; 39(4):1314-20. DOI: 10.1161/STROKEAHA.107.498212. View

3.
Yang Q, Li J, Lu F, Wen A, Xiang J, Zhang L . Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab. 2008; 28(9):1588-96. DOI: 10.1038/jcbfm.2008.50. View

4.
Han H, Qiao Y, Karabiyikoglu M, Giffard R, Yenari M . Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci. 2002; 22(10):3921-8. PMC: 6757647. DOI: 20026332. View

5.
Stirling D, Koochesfahani K, Steeves J, Tetzlaff W . Minocycline as a neuroprotective agent. Neuroscientist. 2005; 11(4):308-22. DOI: 10.1177/1073858405275175. View